Literature DB >> 177726

An improved assay for feline leukaemia virus pseudotypes of murine sarcoma virus.

P H Russell, O Jarrett.   

Abstract

An assay is described for feline leukaemia virus pseudotypes of murine sarcoma virus which increased the virus titre by about 100-fold over conventional assays. The titre is independent of dilution and no secondary focus formation occurs. The assay may be used to study virus neutralization and to detect and type feline leukaemia virus in feline embryo cells by interference.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 177726     DOI： 10.1099/0022-1317-31-1-139

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  5 in total

1.  Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.

Authors:  P R Donahue; E A Hoover; G A Beltz; N Riedel; V M Hirsch; J Overbaugh; J I Mullins
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses.

Authors:  M A Stewart; M Warnock; A Wheeler; N Wilkie; J I Mullins; D E Onions; J C Neil
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

3.  Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma.

Authors:  N Riedel; E A Hoover; P W Gasper; M O Nicolson; J I Mullins
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

4.  Pathogenesis of feline leukemia virus T17: contrasting fates of helper, v-myc, and v-tcr proviruses in secondary tumors.

Authors:  A Terry; R Fulton; M Stewart; D E Onions; J C Neil
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus.

Authors:  Hazel Stewart; Karen W Adema; Elizabeth L McMonagle; Margaret J Hosie; Brian J Willett
Journal:  Retrovirology       Date:  2012-05-31       Impact factor: 4.602
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.